51³Ô¹ÏÍø

Dr Andy Yale

BVMedSci (Hons) BVM BVS (Hons) PGCertVetEd PGDipVCP MVetMed DipECVIM-CA (Oncology) FHEA MRCVS
Lecturer in Veterinary Oncology (CET)

Department: Clinical Science and Services

Campus: Hawkshead

Research Groups: CPCS (Research Programme)

Clinical Groups: Small Animal Oncology

Andy is an RCVS and European Veterinary Specialist in Small Animal Oncology and Lecturer in Veterinary Oncology at the RVC, undertaking clinical work in the Queen Mother Hospital for Animals. Roles include seeing small animal oncology patients, supervising and training oncology residents, teaching undergraduate students, and undertaking research.

Andy graduated from The University of Nottingham before enjoying two years in small animal general practice. He subsequently undertook a small animal rotating internship and medical oncology residency at the 51³Ô¹ÏÍø, also completing a postgraduate diploma and master's degree. He gained his Diploma in Small Animal Oncology and now works as a Lecturer in Veterinary Oncology. 

Clinically, Andy has a particular interest in canine mast cell tumours. His research interests focus on novel diagnostic and therapeutic strategies in veterinary cancer patients, particularly those where there is translational relevance.

Andy is a member of the RVC's Comparative Physiology and Clinical Science (CPCS) Management Committee, managing the Oncology research group, and is also a member of the RVC's clinical research ethical review board (CRERB). He holds a 51³Ô¹ÏÍø Office personal license (PIL) under the Animals (Scientific Procedures) Act. He is Associate Editor of .

Andy contributes to the wider veterinary profession by providing oncology CPD, and has spoken at national and international conferences.

Peer reviewed research publications

Rogato F,  Szladovits B,  Martineau H, Yale A, Mitchell J, Holmes E, Gardner R, Guillén A. Leukemia cutis as a prominent clinical sign in a dog with acute myeloid leukemia. Vet Clin Pathol.  2024; 00: 1-10.  

Yale A, Crawford A, Gramer I, Guillen A, Desmas I, Holmes E. Large granular lymphocyte lymphoma in 65 dogs (2005 - 2023). Vet Comp Oncol. 2023.

Marks T, Rossanese M, Yale A, Stewart S, Smallwood K, Guillen A. Prognostic factors and outcome in cats with thymic epithelial tumours: 64 cases (1999 - 2021). J Small Anim Pract. 2023.

McNally A, Rossanese M, Suárez-Bonnet A, Hardas A, Yale A. Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide. J Vet Intern Med. 2023; 1- 5.

Treggiari E, Pellin M, Romanelli G, Maresca G, Gramer I, Yale A, Pecceu E, Pegnanelli M, Borrego J, Purzycka K, Berlato D. Tonsillar carcinoma in dogs: Treatment outcome and potential prognostic factors in 123 cases. J Vet Intern Med. 2023;1- 11.

Yale A, Priestnall S, Pittaway R, Taylor A. Thymic epithelial tumours in 51 dogs: Histopathologic and clinicopathologic findings. Vet Comp Oncol. 2021;20(1):50-58.

Yale A, Szladovits B, Stell A, Fitzgerald S, Priestnall S, Suarez-Bonnet A. High-Grade Cutaneous Mast Cell Tumour with Widespread Intrathoracic Metastasis and Neoplastic Pericardial Effusion in a Dog. J Comp Pathol. 2020;180:29-34.

Andy is involved with the supervision and training of oncology residents, in addition to teaching undergraduate BVetMed students throughout their 3rd, 4th and 5th years of study. He is rotation leader for the 5th year veterinary students' oncology rotation. Andy has completed a postgraduate certificate in veterinary education and is a fellow of the Higher Education Academy.

Associate Editor of .

Peer reviewer for Veterinary and Comparative Oncology, Veterinary Oncology, Topics in Companion Animal Medicine, and Vet Record Case Reports.

Member of assessment panel for RCVS Advanced Practitioner Status. 

Trustee of Zeus and PJ Foundation.

Top of page